California State Teachers Retirement System (CalSTRS)’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $37.8K | Hold |
2,762
| – | – | ﹤0.01% | 2333 |
|
2025
Q1 | $30.5K | Sell |
2,762
-25,404
| -90% | -$281K | ﹤0.01% | 2413 |
|
2024
Q4 | $300K | Buy |
28,166
+246
| +0.9% | +$2.62K | ﹤0.01% | 2287 |
|
2024
Q3 | $355K | Buy |
27,920
+25,431
| +1,022% | +$323K | ﹤0.01% | 2257 |
|
2024
Q2 | $41.8K | Sell |
2,489
-299
| -11% | -$5.02K | ﹤0.01% | 2449 |
|
2024
Q1 | $41.8K | Sell |
2,788
-1,689
| -38% | -$25.3K | ﹤0.01% | 2521 |
|
2023
Q4 | $67.2K | Buy |
4,477
+160
| +4% | +$2.4K | ﹤0.01% | 2530 |
|
2023
Q3 | $60.5K | Sell |
4,317
-2,191
| -34% | -$30.7K | ﹤0.01% | 2657 |
|
2023
Q2 | $67.4K | Buy |
+6,508
| New | +$67.4K | ﹤0.01% | 2797 |
|
2022
Q2 | – | Sell |
-29,100
| Closed | -$253K | – | 3305 |
|
2022
Q1 | $253K | Sell |
29,100
-3,856
| -12% | -$33.5K | ﹤0.01% | 2599 |
|
2021
Q4 | $313K | Hold |
32,956
| – | – | ﹤0.01% | 2662 |
|
2021
Q3 | $554K | Sell |
32,956
-13,314
| -29% | -$224K | ﹤0.01% | 2437 |
|
2021
Q2 | $707K | Sell |
46,270
-2,518
| -5% | -$38.5K | ﹤0.01% | 2435 |
|
2021
Q1 | $950K | Sell |
48,788
-142
| -0.3% | -$2.77K | ﹤0.01% | 2172 |
|
2020
Q4 | $882K | Buy |
48,930
+958
| +2% | +$17.3K | ﹤0.01% | 2116 |
|
2020
Q3 | $925K | Buy |
47,972
+274
| +0.6% | +$5.28K | ﹤0.01% | 1908 |
|
2020
Q2 | $1.25M | Buy |
47,698
+647
| +1% | +$16.9K | ﹤0.01% | 1740 |
|
2020
Q1 | $839K | Buy |
47,051
+334
| +0.7% | +$5.96K | ﹤0.01% | 1774 |
|
2019
Q4 | $1.56M | Buy |
46,717
+48
| +0.1% | +$1.6K | ﹤0.01% | 1712 |
|
2019
Q3 | $1.11M | Buy |
46,669
+348
| +0.8% | +$8.29K | ﹤0.01% | 1876 |
|
2019
Q2 | $1.67M | Buy |
46,321
+34,446
| +290% | +$1.24M | ﹤0.01% | 1659 |
|
2019
Q1 | $439K | Buy |
11,875
+4,614
| +64% | +$171K | ﹤0.01% | 2380 |
|
2018
Q4 | $313K | Buy |
7,261
+550
| +8% | +$23.7K | ﹤0.01% | 2561 |
|
2018
Q3 | $317K | Hold |
6,711
| – | – | ﹤0.01% | 2685 |
|
2018
Q2 | $334K | Buy |
+6,711
| New | +$334K | ﹤0.01% | 2669 |
|